Endografts are medical implants used to treat aneurysms – ballooning of the vessel wall due to structural weakness. The endograft is a fabric-covered metallic stent that is inserted into an abdominal aortic aneurysm without need for a surgical approach and its resulting side effects. 

The global Aortic Endografts market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Aortic Endografts volume and value at global level, regional level and company level. From a global perspective, this report represents overall Aortic Endografts market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Bolton Medical
Braile Biomedica
Cardiatis
Cook Medical
Cordis (Cardinal Health)
Endologix, Inc.
Endospan
Jotec
Lombard Medical Technologies Plc
Medtronic Plc
Microport Medical
Nano Endoluminal
Terumo Medical Corp.
Transcatheter Technologies
TriVascular Inc.
Vascutek
W. L. Gore and Associates

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Abdominal Aortic Endografts
Thoracic Aortic Endografts
Fenestrated and Branched Aortic Endografts
Flow Diverting Aortic Endografts

Segment by Application
Hospitals
Clinics
Others